These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 20238185)

  • 1. Clinical implication and prognosis of normal baseline cerebral blood flow with impaired vascular reserve in patients with major cerebral artery occlusive disease.
    Isozaki M; Arai Y; Kudo T; Kiyono Y; Kobayashi M; Kubota T; Kikuta K; Okazawa H
    Ann Nucl Med; 2010 Jun; 24(5):371-7. PubMed ID: 20238185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced blood flow and preserved vasoreactivity characterize oxygen hypometabolism due to incomplete infarction in occlusive carotid artery diseases.
    Kuroda S; Shiga T; Ishikawa T; Houkin K; Narita T; Katoh C; Tamaki N; Iwasaki Y
    J Nucl Med; 2004 Jun; 45(6):943-9. PubMed ID: 15181128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of combination therapy with the angiotensin receptor blocker losartan plus hydrochlorothiazide on brain perfusion in patients with both hypertension and cerebral hemodynamic impairment due to symptomatic chronic major cerebral artery steno-occlusive disease: a SPECT study.
    Saura H; Ogasawara K; Suzuki T; Kuroda H; Yamashita T; Kobayashi M; Terasaki K; Ogawa A
    Cerebrovasc Dis; 2012; 33(4):354-61. PubMed ID: 22433127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of central benzodiazepine receptor binding potential/cerebral blood flow SPECT imaging for detecting misery perfusion in patients with unilateral major cerebral artery occlusive diseases: comparison with cerebrovascular reactivity to acetazolamide and cerebral blood flow SPECT imaging.
    Kuroda H; Ogasawara K; Suzuki T; Chida K; Aso K; Kobayashi M; Yoshida K; Terasaki K; Fujiwara S; Kubo Y; Ogawa A
    Clin Nucl Med; 2012 Mar; 37(3):235-40. PubMed ID: 22310248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: a PET study with the acetazolamide test in cerebrovascular disease.
    Okazawa H; Yamauchi H; Toyoda H; Sugimoto K; Fujibayashi Y; Yonekura Y
    J Nucl Med; 2003 Dec; 44(12):1875-83. PubMed ID: 14660711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can the detection of misery perfusion in chronic cerebrovascular disease be based on reductions in baseline CBF and vasoreactivity?
    Okazawa H; Tsuchida T; Kobayashi M; Arai Y; Pagani M; Isozaki M; Yonekura Y
    Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):121-9. PubMed ID: 16896662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assessment of cerebral hemodynamics using perfusion-weighted MRI in patients with major cerebral artery occlusive disease: comparison with positron emission tomography.
    Endo H; Inoue T; Ogasawara K; Fukuda T; Kanbara Y; Ogawa A
    Stroke; 2006 Feb; 37(2):388-92. PubMed ID: 16373637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diastolic blood pressure influences cerebrovascular reactivity measured by means of 123I-iodoamphetamine brain single photon emission computed tomography in medically treated patients with occlusive carotid or middle cerebral artery disease.
    Kimura Y; Oku N; Kajimoto K; Katoh H; Tanaka MR; Takasawa M; Imaizumi M; Kitagawa K; Hori M; Hatazawa J
    Ann Nucl Med; 2006 Apr; 20(3):209-15. PubMed ID: 16715952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET OEF reactivity for hemodynamic compromise in occlusive vascular disease.
    Nemoto EM; Yonas H; Pindzola RR; Kuwabara H; Sashin D; Chang Y; Jovin T
    J Neuroimaging; 2007 Jan; 17(1):54-60. PubMed ID: 17238870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral oxygen metabolism and neuronal integrity in patients with impaired vasoreactivity attributable to occlusive carotid artery disease.
    Kuroda S; Shiga T; Houkin K; Ishikawa T; Katoh C; Tamaki N; Iwasaki Y
    Stroke; 2006 Feb; 37(2):393-8. PubMed ID: 16385090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in vasodilatory capacity and changes in cerebral blood flow induced by acetazolamide in patients with cerebrovascular disease.
    Okazawa H; Yamauchi H; Sugimoto K; Takahashi M
    J Nucl Med; 2003 Sep; 44(9):1371-8. PubMed ID: 12960179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of oxygen extraction fraction on long-term prognosis in patients with reduced blood flow and vasoreactivity because of occlusive carotid artery disease.
    Hokari M; Kuroda S; Shiga T; Nakayama N; Tamaki N; Iwasaki Y
    Surg Neurol; 2009 May; 71(5):532-8; discussion 538, 538-9. PubMed ID: 18514278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating hemodynamic compromise by the OEF response to acetazolamide in occlusive vascular disease.
    Nemoto EM; Yonas H; Kuwabara H; Pindzola R; Sashin D; Chang Y; Jovin T; Gebel J; Hammer MD; Wechsler L
    Adv Exp Med Biol; 2005; 566():135-41. PubMed ID: 16594145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of cerebrovascular reserve in acetazolamide challenge -comparison with acetazolamide challenge H2O-PET and Gas-PET.
    Imaizumi M; Kitagawa K; Oku N; Hashikawa K; Takasawa M; Yoshikawa T; Osaki Y; Matsushita K; Matsumoto M; Hori M; Hatazawa J
    Ann Nucl Med; 2004 Jul; 18(5):369-74. PubMed ID: 15462398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between cerebral circulatory reserve and oxygen extraction fraction in patients with major cerebral artery occlusive disease: a positron emission tomography study.
    Yata K; Suzuki A; Hatazawa J; Shimosegawa E; Nagata K; Sato M; Moroi J
    Stroke; 2006 Feb; 37(2):534-6. PubMed ID: 16410481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of cerebrovascular reserve using xenon-enhanced CT scanning in patients with symptomatic middle cerebral artery stenosis.
    Cao W; Cheng X; Li H; Wang L; Zhang X; Dong Q
    J Clin Neurosci; 2014 Feb; 21(2):293-7. PubMed ID: 24238634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cerebral hemodynamics and risk for recurrent stroke in symptomatic internal carotid artery occlusion].
    Yamauchi H; Fukuyama H; Nagahama Y; Nabatame H; Shio H
    Rinsho Shinkeigaku; 1999 May; 39(5):513-9. PubMed ID: 10424141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetazolamide-augmented dynamic BOLD (aczBOLD) imaging for assessing cerebrovascular reactivity in chronic steno-occlusive disease of the anterior circulation: An initial experience.
    Wu J; Dehkharghani S; Nahab F; Qiu D
    Neuroimage Clin; 2017; 13():116-122. PubMed ID: 27942454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative H2[(15)O]-PET in Pediatric Moyamoya Disease: Evaluating Perfusion before and after Cerebral Revascularization.
    Kuhn FP; Warnock G; Schweingruber T; Sommerauer M; Buck A; Khan N
    J Stroke Cerebrovasc Dis; 2015 May; 24(5):965-71. PubMed ID: 25813061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET evaluation of cerebral hemodynamics in occlusive cerebrovascular disease pre- and postsurgery.
    Kuwabara Y; Ichiya Y; Sasaki M; Yoshida T; Fukumura T; Masuda K; Fujii K; Fukui M
    J Nucl Med; 1998 May; 39(5):760-5. PubMed ID: 9591570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.